StockBoardAsset

Biotech set for upside imbalance.

Long
NASDAQ:HRTX   Heron Therapeutics, Inc.
1
Biotech is set for an upside imbalance if US Equities open strong tomorrow morning.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.